Medicare Proposed $90B in Insurer Audits; UnitedHealth Fell 10%
Wednesday, November 186 Min Read
CMS, the agency that runs Medicare, proposed clawing back overpayments to insurers as far back as 2018 and extrapolating audit errors across whole contracts. Humana, UnitedHealth, Elevance and Centene fell sharply, and the Dow lost 561 points.
13.04%
Humana, November 18
10.21%
UnitedHealth, November 18
$90B
CMS Savings Estimate, 2027-2036
$9B
Recoveries Per Payment Year
In This Piece5 Sections
UnitedHealth fell 10.21% and Humana 13.04% on Wednesday, November 18. The trigger was CRUSH, an anti-fraud proposal released two days earlier by the Centers for Medicare & Medicaid Services.
Elevance lost 7.63% and Centene 7.06% the same day. The Dow fell 561 points (1.11%) to close at 50,198; the S&P 500 slipped 0.23% while the Nasdaq rose 0.42%.
UnitedHealth had already dropped 5.42% the day before. Over two sessions the stock slid from $412 to $350.
What Exactly CMS Proposed
In Medicare Advantage, the government pays insurers a fixed amount per member. That amount rises with the member's recorded diagnoses; the sicker the coding, the bigger the payment.
CMS checks whether those diagnoses are backed by medical records through RADV audits. The new proposal writes three things into rule: sample errors will be extrapolated to the whole contract, extrapolation starts with payment year 2018, and no adjustment factor will be applied.
CMS estimates the change will collect an average of $9 billion in overpayments per payment year. It puts the proposal's total federal savings at nearly $90 billion between 2027 and 2036.
Why This Rule Is Back on the Table
CMS codified the same method in 2023. In September 2025, a federal court in Texas vacated that rule in a case brought by Humana.
The court objected to how the rule was issued, not to the method itself. The government appealed the ruling in November 2025.
So the proposal is not a new idea. It is the rule the court struck down on procedure, rewritten this time with public comment.
How Extrapolation and the Adjuster Change the Math
The difference lies in how many people the error is applied to. The figures below are assumptions chosen to show the method and belong to no specific company.
The fee-for-service adjuster rests on the idea that the government's own traditional Medicare data also contains similar documentation gaps. Humana's lawsuit also challenged the absence of this adjuster; the new proposal again explicitly leaves it out.
That is why the risk depends on how much revenue a company draws from Medicare Advantage, not on how many members get audited. Mizuho analyst Ann Hynes wrote that UnitedHealth and Humana are the most exposed, followed by CVS, Elevance, Centene and Molina.
The Proposal Is Not Yet Binding
Nothing is in force today. The proposal will be published in the Federal Register on November 19, comments run until January 19, 2027, and only a final rule will bind.
Oppenheimer expects the rule to face legal challenges as it did in 2025. The firm says the $90 billion mostly reflects recoupment rather than broad savings, with collections concentrated in 2028-2030.
Pinning the selloff on a single cause would also be wrong. According to Investing.com, Senator Elizabeth Warren that day called for breaking up UnitedHealth, CVS and Cigna by name; sources do not separate the two effects.
Timeline
- 2023CMS codifies extrapolation with no fee-for-service adjuster.
- September 2025A federal court in Texas vacates the rule on procedural grounds.
- November 16, 2026CMS releases the CRUSH proposal.
- November 17, 2026UnitedHealth falls 5.42%, Humana 3.88%.
- November 18, 2026UnitedHealth falls 10.21%, Humana 13.04%.
- January 19, 2027The comment period closes.
Because the Dow is a price-weighted index, UnitedHealth's drop fed straight into it. The company makes up about 4.32% of the index.
What It Means for Investors
- The market priced in the method's return; it has not yet priced a possible court block or recoveries spread over several years.
- Humana and UnitedHealth, at the top of Mizuho's list, fell hardest; in intraday data CVS and Cigna lost less than 3.5%.
- The date to watch is January 19, 2027: if the final text includes an adjuster after comments close, repayment math shrinks.
- The risk to this thesis is the courts: if the government loses its appeal of the 2025 ruling, the new text faces the same test.
The proposal's scope and the $90 billion estimate come from CMS's CMS-6098-P fact sheet. The court history relies on reporting by RISE Health and US Health Insights. Closing data come from Stock Titan and Yahoo Finance's live coverage; analyst comments come from Investing.com and TipRanks. Figures in the worked example are assumptions.
Companies in This Piece
Since The Event